Target intelligence / Profile preview

Longevity regulating pathway - multiple species (Longevity pathway)

Target
Longevity pathway
Molecular classification
Signal transduction pathway, Enzyme family, Transcription factor, Receptor family
01

Overview

The longevity regulating pathway - multiple species is an evolutionarily conserved network of signaling cascades that integrate environmental and nutrient cues to regulate the lifespan and health of an organism [1]. Major components of this network include the insulin/IGF-1 signaling (IIS) pathway, the mechanistic target of rapamycin (mTOR) signaling, the adenosine monophosphate-activated protein kinase (AMPK) pathway, and sirtuin-mediated deacetylation [1][2]. These pathways interact to control critical cellular processes such as autophagy, protein synthesis, mitochondrial biogenesis, and oxidative stress resistance [3]. When nutrients are abundant, pathways like mTOR and IIS promote growth and reproduction, whereas nutrient scarcity or caloric restriction triggers AMPK and sirtuins to shift cellular focus toward maintenance and survival [4]. Therapeutic targeting of these nodes, for instance with mTOR inhibitors like rapamycin or AMPK activators like metformin, aims to delay aging and the onset of associated chronic diseases such as Alzheimer's, cancer, and type 2 diabetes [5].

Other names
Longevity regulating pathwayAging-associated signaling pathwaysNutrient-sensing longevity networkKEGG map04213Conserved longevity signaling
02

Mechanism of action

Modulation of nutrient-sensing and stress-response signaling networks, such as inhibition of the mTORC1 complex or activation of energy-sensing enzymes like AMPK and sirtuins, to promote cellular repair and delay biological senescence [1][5].

03

Biological functions

Lifespan regulationMetabolic homeostasisCellular stress responseAutophagyProteostasis
04

Disease associations

Neurodegenerative diseaseCancerType 2 diabetes mellitusCardiovascular diseaseSarcopenia
05

Safety considerations

ImmunosuppressionMetabolic dysregulation (e.g., hyperglycemia)Gastrointestinal toxicityInhibition of normal growth and developmental processesImpaired wound healing
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

Insulin-like growth factor 1 (IGF-1) levelsAMPK phosphorylation statusSIRT1 protein expressionmTORC1 activity (p-S6K1)Epigenetic clock (DNA methylation age)

Beyond the preview

Go deeper on Longevity regulating pathway - multiple species (Longevity pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longevity regulating pathway - multiple species (Longevity pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call